uk 68798 has been researched along with Tachycardia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, K; Hashimoto, N; Ishiwata, N; Kobayashi, T; Machida, T; Matsuura, J; Miyoshi, S; Nakaya, H; Ogawa, S; Ogino, Y; Tanimoto, K; Yamamoto, W; Yamanaka, Y; Yamashita, T | 1 |
| Jonsson, EN; Karlsson, MO; Lindbom, L; Marshall, S; McFadyen, L; Tunblad, K | 1 |
| Nattel, S; Schram, G; Shinagawa, K; Shiroshita-Takeshita, A | 1 |
| Wolbrette, DL | 1 |
| Decara, JM; Falk, RH | 1 |
| Honerjäger, P; Schmidt, G | 1 |
| Corr, PB; Zuanetti, G | 1 |
3 review(s) available for uk 68798 and Tachycardia
| Article | Year |
|---|---|
Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Conduction System; Humans; Hydantoins; Imidazoles; Imidazolidines; Male; Phenethylamines; Piperazines; Risk Assessment; Risk Factors; Sex Factors; Sotalol; Sulfonamides; Tachycardia; Torsades de Pointes | 2003 |
Dofetilide: a new pure class III antiarrhythmic agent.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Drug Administration Schedule; Electrophysiology; Food-Drug Interactions; Heart Conduction System; Humans; Phenethylamines; Potassium Channel Blockers; Sulfonamides; Tachycardia; Ventricular Dysfunction | 2000 |
[New anti-arrhythmia agents].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Humans; Phenethylamines; Procainamide; Propanolamines; Sotalol; Sulfonamides; Survival Rate; Tachycardia | 1992 |
4 other study(ies) available for uk 68798 and Tachycardia
| Article | Year |
|---|---|
Effects of the selective KACh channel blocker NTC-801 on atrial fibrillation in a canine model of atrial tachypacing: comparison with class Ic and III drugs.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Flecainide; Heart Atria; Heart Conduction System; Phenethylamines; Potassium Channel Blockers; Receptors, Cholinergic; Sulfonamides; Tachycardia | 2014 |
The use of clinical irrelevance criteria in covariate model building with application to dofetilide pharmacokinetic data.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Anti-Arrhythmia Agents; Biomarkers; Clinical Trials, Phase III as Topic; Drug Therapy; Female; Humans; Male; Middle Aged; Models, Statistical; Pharmacokinetics; Phenethylamines; Sulfonamides; Tachycardia; Young Adult | 2008 |
Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channels, L-Type; Dogs; Electrocardiography; Electrophysiology; Flecainide; Heart Atria; Phenethylamines; Refractory Period, Electrophysiological; Sulfonamides; Tachycardia | 2003 |
Antiarrhythmic efficacy of a new class III agent, UK-68,798, during chronic myocardial infarction: evaluation using three-dimensional mapping.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Dogs; Electric Stimulation; Electrocardiography; Heart; Heart Conduction System; Heart Ventricles; Myocardial Infarction; Phenethylamines; Sulfonamides; Tachycardia; Ventricular Fibrillation | 1991 |